These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 36205850)
1. Results of an African American-targeted norm-based colorectal cancer screening intervention: a pilot study. Manning M; Lucas T; Thompson H; Penner L J Behav Med; 2023 Jun; 46(3):391-404. PubMed ID: 36205850 [TBL] [Abstract][Full Text] [Related]
2. Targeting and tailoring message-framing: the moderating effect of racial identity on receptivity to colorectal cancer screening among African-Americans. Lucas T; Manning M; Hayman LW; Blessman J J Behav Med; 2018 Dec; 41(6):747-756. PubMed ID: 29882172 [TBL] [Abstract][Full Text] [Related]
3. Gain versus loss-framed messaging and colorectal cancer screening among African Americans: A preliminary examination of perceived racism and culturally targeted dual messaging. Lucas T; Hayman LW; Blessman JE; Asabigi K; Novak JM Br J Health Psychol; 2016 May; 21(2):249-67. PubMed ID: 26333060 [TBL] [Abstract][Full Text] [Related]
4. Effects of culturally targeted message framing on colorectal cancer screening among African Americans. Lucas T; Thompson HS; Blessman J; Dawadi A; Drolet CE; Hirko KA; Penner LA Health Psychol; 2021 May; 40(5):305-315. PubMed ID: 34152784 [TBL] [Abstract][Full Text] [Related]
5. Culturally targeted message framing and colorectal cancer screening preferences among African Americans. Aspiras O; Lucas T; Thompson HS; Manning MA; Blessman J; Dawadi A; Hirko KA; Penner LA Health Psychol; 2023 Jan; 42(1):1-4. PubMed ID: 36409102 [TBL] [Abstract][Full Text] [Related]
6. Healthcare provider cultural competency and receptivity to colorectal cancer screening among African Americans. Dawadi A; Lucas T; Drolet CE; Thompson HS; Key K; Dailey R; Blessman J Psychol Health Med; 2022 Dec; 27(10):2073-2084. PubMed ID: 34154479 [TBL] [Abstract][Full Text] [Related]
7. Medical mistrust, culturally targeted message framing, and colorectal cancer screening among African Americans. Aspiras O; Lucas T; Thompson HS; Manning MA J Behav Med; 2023 Oct; 46(5):871-881. PubMed ID: 37140761 [TBL] [Abstract][Full Text] [Related]
8. Early Screening of African Americans (45-50 Years Old) in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program. Levin TR; Jensen CD; Chawla NM; Sakoda LC; Lee JK; Zhao WK; Landau MA; Herm A; Eby E; Quesenberry CP; Corley DA Gastroenterology; 2020 Nov; 159(5):1695-1704.e1. PubMed ID: 32702368 [TBL] [Abstract][Full Text] [Related]
9. Exploring perceptions of colorectal cancer and fecal immunochemical testing among African Americans in a North Carolina community. Harden E; Moore A; Melvin C Prev Chronic Dis; 2011 Nov; 8(6):A134. PubMed ID: 22005627 [TBL] [Abstract][Full Text] [Related]
10. Longitudinal adherence to annual colorectal cancer screening among Black persons living in the United States enrolled in a community-based randomized trial. Arevalo M; Sutton SK; Abdulla R; Christy SM; Meade CD; Roetzheim RG; Gwede CK Cancer; 2024 May; 130(9):1684-1692. PubMed ID: 38150285 [TBL] [Abstract][Full Text] [Related]
11. Message Framing for Men? Gender Moderated Effects of Culturally Targeted Message Framing on Colorectal Cancer Screening Receptivity among African Americans. Lucas T; Rogers CR; Aspiras O; Manning M; Dawadi A; Thompson HS Psychol Men Masc; 2023 Apr; 24(2):103-112. PubMed ID: 37193560 [TBL] [Abstract][Full Text] [Related]
12. A community-based trial of educational interventions with fecal immunochemical tests for colorectal cancer screening uptake among blacks in community settings. Christy SM; Davis SN; Williams KR; Zhao X; Govindaraju SK; Quinn GP; Vadaparampil ST; Lin HY; Sutton SK; Roethzeim RR; Shibata D; Meade CD; Gwede CK Cancer; 2016 Nov; 122(21):3288-3296. PubMed ID: 27420119 [TBL] [Abstract][Full Text] [Related]
13. Rates and predictors of colorectal cancer screening by race among motivated men participating in a Prostate Cancer Risk Assessment Program. Hall MJ; Ruth K; Giri VN Cancer; 2012 Jan; 118(2):478-84. PubMed ID: 21751189 [TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of a multicomponent, targeted, low-literacy educational intervention compared with a nontargeted intervention to boost colorectal cancer screening with fecal immunochemical testing in community clinics. Davis SN; Christy SM; Chavarria EA; Abdulla R; Sutton SK; Schmidt AR; Vadaparampil ST; Quinn GP; Simmons VN; Ufondu CB; Ravindra C; Schultz I; Roetzheim RG; Shibata D; Meade CD; Gwede CK Cancer; 2017 Apr; 123(8):1390-1400. PubMed ID: 27906448 [TBL] [Abstract][Full Text] [Related]
15. Text Messaging and Opt-out Mailed Outreach in Colorectal Cancer Screening: a Randomized Clinical Trial. Huf SW; Asch DA; Volpp KG; Reitz C; Mehta SJ J Gen Intern Med; 2021 Jul; 36(7):1958-1964. PubMed ID: 33511567 [TBL] [Abstract][Full Text] [Related]
16. A Pilot Study Examining the Efficacy of Delivering Colorectal Cancer Screening Messages via Virtual Health Assistants. Krieger JL; Neil JM; Duke KA; Zalake MS; Tavassoli F; Vilaro MJ; Wilson-Howard DS; Chavez SY; Laber EB; Davidian M; George TJ; Modave FP; Odedina FT; Lok BC Am J Prev Med; 2021 Aug; 61(2):251-255. PubMed ID: 33888362 [TBL] [Abstract][Full Text] [Related]
17. Barriers and Facilitators to Colorectal Cancer Screening in African-American Men. Earl V; Beasley D; Ye C; Halpin SN; Gauthreaux N; Escoffery C; Chawla S Dig Dis Sci; 2022 Feb; 67(2):463-472. PubMed ID: 33811563 [TBL] [Abstract][Full Text] [Related]
19. Moderators of the effects of perceived racism and discrimination on cancer-related health behaviors among two samples of African Americans. Manning M; Lucas T; Purrington K; Thompson H; Albrecht TL; Penner L Soc Sci Med; 2023 Jan; 316():114982. PubMed ID: 35484000 [TBL] [Abstract][Full Text] [Related]
20. Assessing the effectiveness of a community health advisor plus screen to save educational intervention on stool-based testing adherence in an African American safety net clinic population: study protocol for a randomized pragmatic trial. Luque JS; Matthew OO; Jackson DR; Vargas MA; Austin T; Ali A; Kiros GE; Harris CM; Tawk R; Gwede CK; Wallace K; Jean-Pierre P Trials; 2022 Feb; 23(1):151. PubMed ID: 35168640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]